Medical Device Classification Product Codes

By Effective Medicine  On  In Medical Devices Tagged  

PDF Printer Version Document issued on: April 11, 2013

The draft of this document was issued on January 3, 2012.

For questions regarding this document contact (CDRH) Diane Garcia at 301-796-6559 or [email protected], or (CBER) the Office of Communication, Outreach and Development at 800-835-4709 or 301-827-1800.

CDRH LogoCBER Logo

U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research

Preface

Public Comment

You may submit written comments and suggestions at any time for Agency consideration to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, rm. 1061, (HFA-305), Rockville, MD, 20852. Submit electronic comments to http://www.regulations.gov. Identify all comments with the docket number listed in the notice of availability that publishes in the Federal Register. Comments may not be acted upon by the Agency until the document is next revised or updated.

Additional Copies

Additional copies are available from the Internet. You may also send an e-mail request to [email protected] to receive an electronic copy of the guidance or send a fax request to 301-827-8149 to receive a hard copy. Please use the document number (1774) to identify the guidance you are requesting.

Additional copies of this guidance document are also available from the Center for Biologics Evaluation and Research (CBER) by written request, Office of Communication, Outreach and Development (HFM-40), 1401 Rockville Pike, Suite 200N, Rockville, MD 20852-1448, by telephone, 1-800-835-4709 or 301-827-1800, by email, [email protected], or from the Internet at http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/default.htm.

Medical Device Classification Product Codes – Guidance for Industry and Food and Drug Administration Staff

This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.

1

FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.

2 Note that Section 607 of the Food and Drug Administration Safety and Innovation Act (FDASIA) amended Section 513(f)(2) of the FDC Act to allow submission of a De Novo petition without submission of a 510(k) and subsequent NSE if there is no legally marketed device upon which to base an SE determination. In such cases, a new product code will be assigned at the time that the De Novo petition is granted.
  • Kits – Product codes have been assigned to established convenience kits that are outlined in FDA’s Convenience Kits Interim Regulatory Guidance. The list of established convenience kits can be found in the guidance.

    • 3. Premarket Approval (PMA) Devices and Humanitarian Device Exemption (HDE) Devices

    1. The use of product codes for PMA and HDE devices is similar to their use for 510(k) devices. A product code is assigned to the device upon approval and is included in the subject of the approval letter of a PMA or HDE.
    2. Class III devices are not always classified under a specific regulation, but may have a product code assigned. When a regulation for the device type exists, Class III devices are assigned under a specific regulation, like Class I and II devices. When Class III devices are reclassified to Class II devices, a regulation is created and the product code may remain the same or a new product code may be created.
    3. Modifications to an existing Class III device that result in the submission of a PMA supplement, such as a change in indications for use, which would be submitted through a panel track PMA supplement, may require creation and assignment of a new product code for the modified device.
    4. The appropriate product code should be cited in submissions of annual reports.
    5. For HDE submissions, the eligibility for humanitarian exemption is not based on the product code of the proposed device. The proposed device, along with the indications for use, must be designated as a Humanitarian Use Device by the Office of Orphan Products before an HDE can be submitted to CDRH or CBER.3

    4. Investigational Device Exemption (IDE)

    1. A classification product code may be assigned to a device that is the subject of an IDE submission and included in the approval letter for an IDE if the device falls in a known device area with established technology or will be tracked internally for a specific technology, patient population or device area.
    2. The classification product code assigned to a device that is the subject of an IDE application is primarily used for internal tracking purposes and may differ from that of the final PMA approval or 510(k) clearance. In many instances, a product code will not be assigned to an IDE submission.
    3. For devices where an established classification product code is known, the proposed product code should be specified in the submission. For novel devices, a new classification product code will generally be assigned by FDA at the time of PMA approval/510(k) clearance.

    5. Request for Classification (513(g)) Applications

    Section 513(g) of the FDC Act (21 U.S.C. 360c(g)) provides a means to obtain the Agency’s views about the classification and the regulatory requirements that may be applicable to a particular device. FDA’s response to a 513(g) request will include, in part, the Agency’s assessment, based on the information submitted in the request, as to the generic type of device (e.g., classification regulation) that the requester’s device appears to be within (if any); the class of devices within that generic type; and whether a PMA, 510(k), or neither is required in order to market devices of the particular class within that generic type. However, a classification product code is not generally specified in a 513(g) classification for devices that will require a premarket submission. The recommendation in response to the 513(g) submission only lists proposed devices within a given regulation. Devices that are Class I exempt or Class II exempt may receive a classification product code as part of this recommendation.

    Use of Classification Product Codes in Post Market Review

    1. Adverse Events

    Classification product codes are a key element in the reporting of adverse events and product problems in medical device reports (MDRs). Though not clearly requested in the 3500A mandatory reporting form (MedWatch Form), it is common practice for the reporter to indicate the product code along with the common name of the device in section D2 of the 3500A form. The addition of the product code by mandatory reporters supports 21 CFR 803.52(c)(2) by describing the type of product. The classification product code used by reporters should be the primary product code associated with the device for which the report is being made. To improve the quality of MDRs, we recommend that reporters include the premarket submission number (if applicable) in section G5 of the 3500A form to further link the device to its original classification.

    In cases where the classification product code is not known by the reporter and an MDR is submitted without one, CDRH assigns the appropriate product code to the MDR based on the brand name (section D1), common device name (section D2), or premarket submission number (section D5). However, it is preferred that the reporter of the MDR provide the product code with which CDRH classified the device (in the case of Class II and III devices).

    2. Import/Export

    A. Office of Regulatory Affairs (ORA) Product Code Builder

    In order to ensure that a medical device is in compliance with FDA regulatory requirements, importers/brokers/filers are required to submit certain import information. One data element that is required to be provided is the product code. If the product code is unknown, importers/brokers/filers can use the Office of Regulatory Affairs’ (ORA) Product Code Builder to formulate a product code for the product they are importing. In addition, the CDRH Product Classification Database can be used to look up a device’s definition and regulatory requirements, neither of which is provided in the ORA Product Code Builder. As new product codes are created by CDRH and old ones modified, ORA’s Division of Compliance Systems (DCS) is notified, and the Product Code Builder is updated. The product code used for the FDA import admissibility review process is formatted differently than the classification product code used by CDRH. There is no definitive meaning for the three digit classification product codes in CDRH’s Product Classification Database. However, ORA’s Product Code Builder uses a seven digit product code, rather than the three letter combination found in the product code database. The seven digit product codes encompass devices, foods, drugs, biologics, and cosmetics and each digit signifies a particular description. For example, FRN is the product code assigned to Pump, Infusion in CDRH’s Product Classification Database. The same product code translates to 80F–RN in ORA’s Product Code Builder. The two numbers at the beginning of the seven-digit product code represent the medical specialty panel classified for the device.

    B. Import Entry Process

    The classification product code helps the FDA import entry reviewer determine what information he/she should verify to ensure the medical device meets all FDA regulatory requirements (e.g., registration, listing, clearance/approval numbers).

    Classification product codes are also used by FDA to designate products for Import Alerts. Import Alerts identify problem commodities, shippers and importers, and provide guidance for import coverage.

    3. Recalls

    Classification product codes are an important aspect in reporting recalls, corrections and removals. They are used to ensure correct device identification to determine which group of the FDA will be responsible for review and classification of the recall, correction or removal. Though not clearly required in 21 CFR 806.10, the addition of the product code by device manufacturers and importers supports the requirement in 21 CFR 806.10(c)(4) to provide the device’s marketing status, since the product code is assigned during pre-market review or approval (510(k), PMA, HDE or EUA (Emergency Use Authorization)) and indicates the regulatory classification of the device. The device manufacturers and importers should provide the primary product code associated with the recalled device, unless the secondary product code is more specific. In cases where the product code is not known by the device manufacturer or importer, the product code assigned to the device during device listing (Establishment Registration and Device Listing) should be used.

    4. Establishment Registration and Device Listing

    A. Determining How FDA Will Classify Your Device

    If your product is considered a medical device, you must determine how your device is classified by FDA for the purposes of registration and listing.4 Step- by-step instructions on determining how FDA will classify your device can be found on the FDA website.5 Here you will identify the correct device name, regulation number, and classification product code for your device. You will use this information to list your device in the FDA Unified Registration and Listing System (FURLS)/Device Registration and Listing Module (DRLM). If you need assistance with determining if your product is a device or the appropriate classification for the device, please contact the Division of Small Manufacturers, International, and Consumer Assistance (DSMICA) by email at [email protected] to receive assistance.

    B. Listing Your Device

    Instructions for listing your device are posted on our website6 under the “Initial Registration” heading.

    i. Exempt Devices

    Devices that are notsubject to premarket notification (510(k)), premarket approval (PMA) or HDE requirements are considered exempt devices. You will need to determine the classification product code for your exempt device before you can list the device in FURLS/DRLM. You can identify the product code by searching the Product Classification database. Once you know the classification product code, you can list the device.

    ii. Non-Exempt Devices

    Devices that are subject to premarket notification or premarket approval requirements [510(k), PMA] are considered non-exempt devices. If your device requires premarket notification clearance or approval (510(k) or PMA), please remember the following:

    • You cannot list the device until the 510(k) or PMA has been cleared or approved.
    • You need your premarket submission number to list your device in FURLS/DRLM.
    • You should list your device with the Premarket Submission Number (510(k), PMA). The classification product code that was assigned on your clearance/approval letter will appear on your listing.
    • If you believe the classification product code in the CDRH Corporate database is not correct, then you will need to contact the Program Operations Staff (POS) in ODE for assistance with correcting this information. Contact information is listed in the Resource Section of this guidance document.

    iii. Devices Licensed as Biological Products under the PHS Act

    Manufacturers of devices regulated by CBER under the PHS Act, i.e., manufacturers of licensed in vitro diagnostics including donor screening tests, should follow the registration and listing requirements in 21 CFR 607.20 and refer to the section “Product Codes for Licensed Devices in CBER” later in this guidance.

    C. Enforcement Discretion

    Devices for which FDA applies enforcement discretion and therefore pre-market review is not necessary, require additional instructions before they can be listed in FURLS/DRLM. You should contact the Registration and Listing Staff by email at [email protected] to obtain the additional instructions prior to attempting to list such a device. A few devices for which FDA applies enforcement direction are certain kits and export only devices.

    i. Convenience Kits

    You should consider the following before listing a convenience kit:

    Flowchart. Does the convenience kit meet the requirements listed in the Convenience Kit Interim Regulatory Guidance Document? If no, you may not list the classification product code using a kit code; each item in the kit will have to be listed separately using a 510(k) or exempt classification product code. If yes, is the convenience kit of a type matching one of those included on the list attached to the guidance document? If no, see previous no response. If yes, search the product classification database to determine the product code for your kit. Did you find a product code that matches the description of your convenience kit? If yes, once you determine the product code, please contact the Registration and Listing staff by email at reglist@cdrh.fda.gov for assistance with using your kit. If no, if you are unable to find a product code for your kit, please contact the Program Operation Staff in the Office of Device Evaluation (ODE) at 301-796-5640 to obtain a product code for your kit.

    Convenience Kit Interim Regulatory Guidance Document Product Classification Database

    ii. US Manufacturers of Export Only Devices

    US manufacturers of Export Only Devices are required to list the devices that they export to a foreign country.7 However, 510(k) clearance or PMA/HDE approval is not needed for the device to be exported to the foreign country. Some manufacturers of export only devices may market the same device in the United States. In this case, the manufacturer uses the classification product code assigned to the cleared/approved device to list their device in FURLS/DRLM. If the manufacturer is not marketing the same device in the United States, they should contact the Program Operations Staff and obtain a new classification product code for “export only”. Once a new classification product code is assigned, please contact the Registration and Listing Staff by email at [email protected] for assistance with listing devices that are being exported to a foreign country.

    Product Codes for Licensed Devices in CBER

    CBER regulates a range of devices, most of which are subject to the FDC Act only. However, some CBER devices are licensed under the PHS Act (e.g., in vitro diagnostic tests required for blood donor screening and related blood banking practices). Consequently, licensed devices are subject to the regulations outlined in 21 CFR Part 600 in addition to those in 21 CFR Part 800. The different regulatory requirements impact classification product codes as well.

    In contrast, product codes for licensed devices are generated using the principles which apply to most other FDA regulated products (please refer to the Import section). As is the case with other biologics, licensed devices are classified under industry code 57. For example, a licensed blood donor screening assay for Hepatitis B surface antigen has a six character product code of the following structure: 57 V H-05. Of note, the letter in the subclass element can either be an H, I or L, depending whether this is a final product, intended for further manufacture or product sample for testing/lot release.

    Appendix A. Frequently Asked Questions

    1. I have a device for export only. I cannot find the appropriate classification product code in the classification database, how would I be able to successfully list the device?

    Answer: You should contact the Program Operations Staff in order to have a new product code created for the intent of export only.

    2. How do I search for a classification product code?

    Answer: You can search for a product code using the Product Classification Database on FDA’s website: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/PCDSimpleSearch.cfm

    3. I have searched the product code database and do not find a suitable classification product code for my device. What should I do?

    Answer: You can contact the appropriate review division within CDRH/CBER. You may also submit a Request for Classification (513(g)) application.8

    4. How do I update/change a classification product code?

    Answer: Contact the Product Code Coordinator at 301-796-5640.

    5. What do I do if the classification product code on my 510(k) substantially equivalent (SE) or PMA approval letter is incorrect?

    Answer: Contact the appropriate review division within CDRH/CBER. The contact information will be at the bottom of the SE letter or approval letter. If the classification product code is incorrect, they will make the correction and send you a corrected clearance or approval letter.

    6. What happens to the classification product code when the device is reclassified?

    Answer: The product code database will be updated to reflect the new information and the affected firms will be notified in writing in a timely manner.

    7. What should I do if I notice an error in the product classification database?

    Answer: Contact the product code coordinator at 301-796-5640 and the database will be corrected. The product classification database found at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/PCDSimpleSearch.cfm is updated weekly.

    8. What is the difference in review time if a submission requires the creation of a new product code?

    Answer: There is no difference in the review time when a new product code is needed.

    9. Does FDA work with the Centers for Medicare and Medicaid Services (CMS) on product codes for reimbursement issues?

    Answer: No. FDA will provide information to CMS regarding the regulatory requirements associated with a specific product code, but is not further involved in the reimbursement process. For reimbursement issues, CMS should be contacted directly.9

    10. Is it helpful to include a classification product code on my adverse event report?

    Answer: Absolutely, it improves the quality of data reporting and appropriate routing of the report for analysis.

    Appendix B. Resources

    1 An unclassified device is a pre-amendments device for which a classification regulation has not been promulgated. Unclassified devices require submission of a 510(k) premarket notification to CDRH. A not-classified device is a post-amendments device for which the Agency has not yet reviewed a marketing application or for which the Agency has not made a final decision on such a marketing application. A pre-amendments device is a device that was on the market prior to the enactment of the Medical Device Amendments to the FDC Act on May 28, 1976.

    2 See Guidance for Evaluation of Automatic Class III Designation.

    3 For additional information regarding HUD designation, refer to information on the FDA website.

    4 See 21 CFR Part 807.

    5Device Advice: Comprehensive Regulatory Assistance

    6How to Register and List

    7 See 21 CFR Part 807.

    8 Refer to the Draft Guidance for Industry and FDA Staff: FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act on FDA’s website, and the Draft Guidance for Industry and FDA Staff: User Fees for 513(g) Requests for Classification Information.

    9 See https://www.cms.gov/



    Related Posts